Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HARMONY BIOSCIENCES HOLDINGS, INC.

(HRMY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about HARMONY BIOSCIENCES HOLDINGS, INC.
01/10INSIDER SELL : Harmony Biosciences Holdings
MT
01/07INSIDER SELL : Harmony Biosciences Holdings
MT
01/05Harmony Biosciences to Participate in 40th Annual J.P. Morgan Healthcare Conference
PR
2021HARMONY BIOSCIENCES HOLDINGS, INC.(N : HRMY) added to S&P Pharmaceuticals Select Industry ..
CI
2021HARMONY BIOSCIENCES HOLDINGS, INC.(N : HRMY) added to NASDAQ Biotechnology Index
CI
2021Harmony Biosciences to be Included in Nasdaq Biotechnology Index
MT
2021Harmony Biosciences to be Added to the Nasdaq Biotech Index
PR
2021Harmony Biosciences Publishes Pitolisant Efficacy Data In CNS Drugs
PR
2021Harmony Biosciences Holdings, Inc. Publishes Pitolisant Efficacy Data In CNS Drugs
CI
2021INSIDER SELL : Harmony Biosciences Holdings
MT
2021Harmony Biosciences to Conduct Phase 3 Trial of Pitolisant for Treatment of Idiopathic ..
MT
2021Oppenheimer Initiates Harmony Biosciences With Outperform Rating, $55 Price Target
MT
2021Harmony Biosciences Announces Plans To Initiate Phase 3 Clinical Trial For Treatment Of..
PR
2021Harmony Biosciences Holdings, Inc. Announces Plans To Initiate Phase 3 Clinical Trial F..
CI
2021HARMONY BIOSCIENCES : APPOINTS LINDA SZYPER TO ITS BOARD OF DIRECTORS - Form 8-K
PU
More most relevant news
All news about HARMONY BIOSCIENCES HOLDINGS, INC.
01/10INSIDER SELL : Harmony Biosciences Holdings
MT
01/07INSIDER SELL : Harmony Biosciences Holdings
MT
01/05Harmony Biosciences to Participate in 40th Annual J.P. Morgan Healthcare Conference
PR
2021HARMONY BIOSCIENCES HOLDINGS, INC.(N : HRMY) added to S&P Pharmaceuticals Select Industry ..
CI
2021HARMONY BIOSCIENCES HOLDINGS, INC.(N : HRMY) added to NASDAQ Biotechnology Index
CI
2021Harmony Biosciences to be Included in Nasdaq Biotechnology Index
MT
2021Harmony Biosciences to be Added to the Nasdaq Biotech Index
PR
2021Harmony Biosciences Publishes Pitolisant Efficacy Data In CNS Drugs
PR
2021Harmony Biosciences Holdings, Inc. Publishes Pitolisant Efficacy Data In CNS Drugs
CI
2021INSIDER SELL : Harmony Biosciences Holdings
MT
More news
News in other languages on HARMONY BIOSCIENCES HOLDINGS, INC.
2021Harmony Biosciences fait partie de l'indice Nasdaq des biotechnologies
2021Harmony Biosciences va mener un essai de phase 3 sur le Pitolisant pour le traitement d..
2021Harmony Biosciences annonce une hausse de ses bénéfices et de son chiffre d'affaires au..
2021Les actions du secteur de la santé contribuent à la reprise de mardi en fin de séance
2021Les actions du secteur de la santé progressent mardi
2021Kite Realty Group Trust remplacera Lending Tree dans le S&P MidCap 400 le 22 octobre ; ..
2021Kite Realty Group Trust remplacera Lending Tree dans le S&P MidCap 400 le 22 octobre ; ..
2021Un médicament de Harmony Biosciences est recommandé par l'American Academy of Sleep Med..
2021Harmony Biosciences Holdings, Inc. fournit des prévisions de revenus pour le second sem..
2021MISE À JOUR : les actions de Harmony Biosciences bondissent après la surprise des gains du..
More news
Analyst Recommendations on HARMONY BIOSCIENCES HOLDINGS, INC.
2021Oppenheimer Initiates Harmony Biosciences With Outperform Rating, $55 Price Target
MT
2021Raymond James Starts Harmony Biosciences Holdings at Outperform With $58 Price Target
MT
2021HARMONY BIOSCIENCES : Needham Starts Harmony Biosciences Holdings at Buy With $57 Price Ta..
MT
2021HARMONY BIOSCIENCES : Goldman Sachs Upgrades Harmony Biosciences Holdings to Buy From Neut..
MT
More recommendations
Press releases
01/05Harmony Biosciences to Participate in 40th Annual J.P. Morgan Healthcare Conference
PR
2021Harmony Biosciences to be Added to the Nasdaq Biotech Index
PR
2021Harmony Biosciences Publishes Pitolisant Efficacy Data In CNS Drugs
PR
2021Harmony Biosciences Announces Plans To Initiate Phase 3 Clinical Trial For Treatment Of..
PR
2021HARMONY BIOSCIENCES : APPOINTS LINDA SZYPER TO ITS BOARD OF DIRECTORS - Form 8-K
PU
More press releases
Upcoming event on HARMONY BIOSCIENCES HOLDINGS, INC.